No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
SILO Silo Pharma
- 0.960
- -0.090-8.55%
Close Jun 18 16:00 ET
- 0.990
- +0.030+3.13%
Post 19:54 ET
3.54MMarket Cap-806P/E (TTM)
1.070High0.960Low135.38KVolume1.070Open1.050Pre Close135.24KTurnover4.05%Turnover RatioLossP/E (Static)3.69MShares3.05052wk High0.67P/B3.21MFloat Cap0.96052wk Low--Dividend TTM3.34MShs Float19.500Historical High--Div YieldTTM10.48%Amplitude0.960Historical Low0.998Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Silo Pharma(SILO.US) Officer Buys US$5,533.14 in Common Stock
$Silo Pharma(SILO.US)$ Officer Weisblum Eric purchased 5,000 shares of common stock on Jun 11, 12, 2024 at an average price of $1.11 for a total value of $5,533.14.Source: Announcement What is stateme
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersViracta Therapeutics (NASDAQ:VIRX) stock increased by 16.8% to $0.68 during Tuesday's pre-market session. The company's market cap stands at $26.7 million. Purple Biotech (NASDAQ:PPBT) stock in
Silo Pharma Close to Achieving Optimal Formulation for Ketamine Implant
Silo Pharma (SILO) said Friday it has moved closer to achieving the optimal formulation for its SP-26 ketamine implant to treat chronic pain and fibromyalgia. The developmental stage biopharmaceutical
Express News | Silo Pharma Announces Successful Development Milestones For SP-26 Ketamine Implant Therapeutic Targeting Fibromyalgia And Chronic Pain
Express News | Silo Pharma Announces Successful Production of Its SP-26 Ketamine Implant for Fibromyalgia
Express News | Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Comments
$Silo Pharma(SILO.US$ Loading more now
Silo Pharma Announces Successful Production of SP-26 Ketamine Implant for Fibromyalgia.
Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, has recently announced successful development activities for its SP-26 ketamine implant therapeutic ta...
Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, has recently announced successful development activities for its SP-26 ketamine implant therapeutic ta...
$Silo Pharma(SILO.US$ loading here
$Silo Pharma(SILO.US$ Yup SS’s can’t resist! With it being HTB they can’t afford to let it get to high or they would have to use naked shares to fight back! Hehehe
11
$Silo Pharma(SILO.US$ Announces Successful Production of Its SP-26 Ketamine Implant for Fibromyalgia
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg